Introduction
Tatumella ptyseos is a rod-shaped, Gram-negative facultative anaerobic bacteria belonging to the Enterobacteriaceae family and assigned to the family of Erwiniaceae in 2016 [1] . This bacteria, previously known as the CDC group EF-9, was first described by Hollis et al. in 1981 [2] but the genus and species, T. ptyseos, was not validly named until 1982 [3] . The scientific information about this organism, rarely isolated in clinical sample, is limited. The differences between T. ptyseos and other Enterobacteriacae are the large inhibition zone around penicillin, the tendency to die in blood agar in 7 days and the small number of flagella [2, 4] . Since the first description, six different species from the Tatumella genus were described: T. citrea, T. punctata, T. terrae, and T. morbirosei were originally recovered from fruit, and T. ptyseos and T. saanichensis from human materials. Two species of this genus are associated with clinical disease in humans: T. psyseos and T. citrea. T. ptyseos has already been identified in human and animal materials such as blood, sputum, stool, urinary tract, abdominal tumor, and venous catheter [5] , but also from soil, beef, grapes [6] , and pineapples (T. citrea, described in Japan [7] ). T. ptyseos was associated to severe neonatal sepsis of children infested by powdered infant formula milk [8] and was also reported to cause severe sepsis in adults [5] . Globally, less than 10 blood-isolated human case reports were found after a PubMed search (keywords: Tatumella, T. ptyseos, T. genus, EF-9). This is the first report of human infection in Switzerland.
Case Report
In August 2017, an 81-year-old woman was admitted at the emergency department of the CHUV in Lausanne with acute confusion and severe sepsis. The patient presented a cervix adenosquamous carcinoma diagnosed in 2016 and treated by chemo-radiotherapy (carboplatin AUC2 during 13 months).
On admission, she was hypotensive (92/44 mmHg) and hypothermic (35°C) with abdominal pain. The status showed a heart rate at 82/min and respiratory rate at 15/ min with the SaO 2 measured at 97%. An empirical antibiotic therapy with ceftriaxone was initiated. Blood tests showed an inflammatory syndrome (CRP, 98 mg/L), leukocytosis at 20,800 G/L (4000-10,000 G/L), and hemoglobin at 81 g/L (117-157 g/L). There was no renal nor hepatic failure. The chest X-ray ( Fig. 1 ) and the urine analysis were normal. Blood cultures and a vaginal smear were performed prior antibiotic initiation. One aerobic bottle out of three pairs of inoculated aerobic and anaerobic blood bottles incubated in an automated Bactec FX (Becton Dickinson) was positive after 12-h incubation. The positive bottle contained a Gram-negative rod-shaped bacteria which was identified by MALDI-TOF as Tatumella ptyseos with a Bruker score higher than 2. The identification of this bacteria was performed on a Bruker MALDI-TOF (Biotyper 4.1 (version 80)) with the MBT 7311 MSP Library (#1829023) which includes mass spectrum profiles of T. ptyseos [2] , T. citrea [4] , T. punctata [4] , and T. terrae [2] . At least two other described Tatumella spp. are not in the MSP Library, T. morbirosei and T. saanichensis. Due to a poor representation of Tatumella spp. in the Bruker database, the identification of T. ptyseos was confirmed by 16S rRNA gene sequencing with a 100% identity on a 448-bp length sequence. Ceftriaxone was shifted to cefepime, although retrospectively the susceptibility profile was adapted, due to the potential presence of AmpC betalactamases. The vaginal smear showed a bacterial vaginosis with Bacteroides fragilis (treated by metronidazole 500 mg bid for 7 days). The abdominal CT (Fig. 2) showed a progression of the uteral tumor. There was no other evidence for the origin of the bacteremia. The evolution of the bacteremia was favorable and the patient was discharged to a palliative care unit. She died in September 2017 from her carcinoma progression.
Antimicrobial Susceptibility and Minimal Inhibitory Concentration
Antimicrobial susceptibility test was performed using the disc diffusion method according to Clinical and Laboratory Standards Institute (CLSI) recommendations. The results of the antibiotic tests performed by the disc method are shown in Table 1 . The determination of the minimal inhibitory concentrations of antimicrobial agents was only performed for ceftazidime (minimal inhibitory concentration (MIC), 0.016), ceftriaxone (MIC, 0.12), and cefepime (< 0.016). A phenotypic Etest for the detection of AmpC beta-lactamase (cefotetan/cefotetan+cloxa-cillin; Liofilchem, Italy) was negative, but does not exclude the presence of an inducible AmpC beta-lactamase.
Discussion
Tatumella ptyseos can be described as an opportunistic pathogen with described case reports from nosocomial and community-acquired infection [2, 8] . The most common isolation site is sputum whereas bacteremia remains unusual [2, 4] . In this case report, the source of the bacteremia was not documented. The patient was immunosuppressed with a cancer and this immunosuppression could have favored an environmental acquisition of the opportunistic pathogen, since a gynecological initial site has not been described yet in the literature. The Bruker MBT 7311 MSP Library does only contain a few MSPs of Tatumella spp. not covering enough species and strains to provide robust identification at the species level. Thus, a misidentification of Tatumella spp. including T. ptyseos cannot be excluded, even with a Bruker score above 2. Therefore, a 16S rRNA gene sequencing is recommended to confirm the MALDI-TOF identification at the species level until further enrichment of the library with additional Tatumella spp.
The sensitivity of T. ptyseos to antimicrobial agents varies in the different case report available. For our patient, T. ptyseos was sensitive to all of the antibiotics tested. In many Enterobacteriaceae, AmpC expression is low but inducible in response to β-lactam exposure and can also be expressed constitutively at high level following mutations of components involved in the regulatory pathways. Overexpression confers resistance to broad-spectrum cephalosporins including cefotaxime, ceftazidime, and ceftriaxone [9] that obligates the use of carbapenem or cefepime [10] . After identification, we modified the treatment accordingly and chose cefepime for those reasons.
The expected course of T. ptyseos infection is generally favorable with no death reported in the medical literature. We summarized the T. ptyseos infection characteristics available in the literature in Table 2 . In our case, the evolution was favorable under cefepime treatment and the blood cultures became sterile after 48 h.
T. ptyseos infection is a rare cause of infection often described in immunosuppressed patients; inducible AmpC expression should be systematically considered to propose the best molecule for treatment. 
